TY - JOUR

T1 - Коморбидность и дифференциация идиопатической нормотензивной гидроцефалии и болезни Альцгеймера

AU - Smolyannikova, Anna V.

AU - Lobzin, Vladimir Y.

AU - Emelin, Andrey Y.

AU - Gavrilov, Gaspar V.

AU - Kolmakova, Kristina A.

AU - Litvinenko, Igor V.

PY - 2025/11/5

Y1 - 2025/11/5

N2 - BACKGROUND: The progression of intellectual and memory impairment is a pressing public health challenge and often leads to disability in older adults. Idiopathic normal pressure hydrocephalus represents one of the causes of dementia and is frequently comorbid with neurodegenerative disorders, particularly Alzheimer disease. Such comorbidity substantially complicates differential diagnosis. Therefore, the search of diagnostic algorithms that allow clinicians to address this problem is essential. AIM: This work aimed to improve the diagnostic accuracy of idiopathic normal pressure hydrocephalus, Alzheimer disease, and their combination by applying a comprehensive clinical, neuropsychological, laboratory, and neuroimaging assessment. METHODS: All patients (171 individuals) were divided into groups according to the disease. All subjects underwent extended neuropsychological testing, gait assessment using standardized scales, neuroimaging interpretation using neuroradiological scales, and cerebrospinal fluid biomarker assay of amyloidogenic and tau-pathology–related proteins. RESULTS: Patients with normal pressure hydrocephalus demonstrated a predominantly dysregulatory cognitive impairment pattern, whereas memory impairment was secondary. In the combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome, both dysregulatory and amnestic patterns coexisted (with the amnestic component predominating). Markedly reduced gait speed was a highly sensitive marker of idiopathic normal pressure hydrocephalus. Patients with the comorbidity also demonstrated reduced gait speed, although to a lesser degree. Cerebrospinal fluid biomarker profile in normal pressure hydrocephalus was characterized by reduced tau and phosphorylated tau levels with normal β-amyloid. In contrast, comorbid patients demonstrated reduced β-amyloid and increased tau and phosphorylated tau concentrations. Neuroimaging analysis revealed that idiopathic normal pressure hydrocephalus is characterized by pronounced ventricular enlargement in the absence of substantial cortical atrophy. Typical features include an acute callosal angle, elevated Evans Index and Z-Evans Index, and a

AB - BACKGROUND: The progression of intellectual and memory impairment is a pressing public health challenge and often leads to disability in older adults. Idiopathic normal pressure hydrocephalus represents one of the causes of dementia and is frequently comorbid with neurodegenerative disorders, particularly Alzheimer disease. Such comorbidity substantially complicates differential diagnosis. Therefore, the search of diagnostic algorithms that allow clinicians to address this problem is essential. AIM: This work aimed to improve the diagnostic accuracy of idiopathic normal pressure hydrocephalus, Alzheimer disease, and their combination by applying a comprehensive clinical, neuropsychological, laboratory, and neuroimaging assessment. METHODS: All patients (171 individuals) were divided into groups according to the disease. All subjects underwent extended neuropsychological testing, gait assessment using standardized scales, neuroimaging interpretation using neuroradiological scales, and cerebrospinal fluid biomarker assay of amyloidogenic and tau-pathology–related proteins. RESULTS: Patients with normal pressure hydrocephalus demonstrated a predominantly dysregulatory cognitive impairment pattern, whereas memory impairment was secondary. In the combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome, both dysregulatory and amnestic patterns coexisted (with the amnestic component predominating). Markedly reduced gait speed was a highly sensitive marker of idiopathic normal pressure hydrocephalus. Patients with the comorbidity also demonstrated reduced gait speed, although to a lesser degree. Cerebrospinal fluid biomarker profile in normal pressure hydrocephalus was characterized by reduced tau and phosphorylated tau levels with normal β-amyloid. In contrast, comorbid patients demonstrated reduced β-amyloid and increased tau and phosphorylated tau concentrations. Neuroimaging analysis revealed that idiopathic normal pressure hydrocephalus is characterized by pronounced ventricular enlargement in the absence of substantial cortical atrophy. Typical features include an acute callosal angle, elevated Evans Index and Z-Evans Index, and a

KW - Alzheimer disease

KW - amyloid biomarkers

KW - combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome

KW - neuroimaging

KW - neuropsychological testing

KW - normal pressure hydrocephalus

UR - https://www.mendeley.com/catalogue/8f77046d-30d4-3d31-afed-9a2fe7f85c43/

UR - https://www.mendeley.com/catalogue/8f77046d-30d4-3d31-afed-9a2fe7f85c43/

U2 - 10.17816/rmmar690457

DO - 10.17816/rmmar690457

M3 - статья

VL - 44

SP - 445

EP - 454

JO - Известия Российской Военно-медицинской академии

JF - Известия Российской Военно-медицинской академии

SN - 2713-2315

IS - 4

ER -